Skip to main content
DNA Labs India

PTCH2 Gene Basal cell nevus syndrome due to germline PTCH2 mutation NGS Genetic Test

DNA Labs India | ISO 9001:2015 Certified

PTCH2 Gene Basal cell nevus syndrome due to germline PTCH2 mutation NGS Genetic Test

Short Name: PTCH2 BCNS NGS Test

Also known as: Gorlin-Goltz Syndrome, Basal Cell Nevus Syndrome, BCNS

PTCH2 Gene Basal cell nevus syndrome due to germline PTCH2 mutation NGS Genetic Test test available at DNA Labs India for ₹20,000. Uses Next-Generation Sequencing (NGS) on Blood or Extracted DNA or One drop Blood on FTA Card samples. Results in 3-4 weeks. Free home collection in 300+ cities across India.

Next-Generation Sequencing (NGS)🏠 Home Collection

🩺 Medically Reviewed By

Overview

The purpose of the PTCH2 Gene Basal Cell Nevus Syndrome NGS Genetic Test is to detect germline mutations in the PTCH2 gene associated with Basal Cell Nevus Syndrome (Gorlin-Goltz syndrome). This test aids in confirming diagnosis, assessing risk for family members, guiding personalized treatment plans, and facilitating early intervention to manage symptoms and reduce cancer risk.

Test Code
2827
Price
₹20,000
Sample Type
Blood or Extracted DNA or One drop Blood on FTA Card
Result Time
3-4 weeks
Fasting Required
No
Method
Next-Generation Sequencing (NGS)
Step 1

Sample Collection

Ensure genetic counseling is scheduled. Provide detailed clinical and family history. No specific fasting required, but follow lab instructions for sample handling.

Method: Venipuncture

Step 2

Laboratory Analysis

Blood sample collected via venipuncture by a trained phlebotomist. For FTA card, a single drop of blood is applied. Ensure proper labeling and documentation.

Step 3

Report Delivery

Apply pressure to the puncture site to prevent bruising. Store sample as per lab guidelines. Await report delivery in 3-4 weeks.

Timeline: 3-4 weeks

Patient Instructions

1
Before the Test:Genetic counseling to discuss test implications, risks, and benefits. Provide informed consent and detailed medical history.
2
During the Test:Sample collection via blood draw or FTA card. Minimal discomfort similar to routine blood tests.
3
After the Test:Wait for report in 3-4 weeks. Schedule follow-up with healthcare provider to interpret results and plan next steps.

About This Test

Who Should Get This Test

The purpose of the PTCH2 Gene Basal Cell Nevus Syndrome NGS Genetic Test is to detect germline mutations in the PTCH2 gene associated with Basal Cell Nevus Syndrome (Gorlin-Goltz syndrome). This test aids in confirming diagnosis, assessing risk for family members, guiding personalized treatment plans, and facilitating early intervention to manage symptoms and reduce cancer risk.

How to Prepare

  • Use sterile equipment for blood collection
  • Label samples accurately with patient details
  • Transport samples at ambient temperature unless specified
  • For FTA cards, allow blood to dry completely before packaging

Doctor's Notes

Reviewed by — MBBS, MD (Medical Genetics) · Reg. No. 8532

"Early genetic testing for PTCH2 mutations can aid in timely management and surveillance of Basal Cell Nevus Syndrome, reducing complications from skin cancers and other symptoms."

Last medically reviewed: September 7, 2026

Test Parameters & Specifications

Sample TypeBlood or Extracted DNA or One drop Blood on FTA Card
ContainerEDTA tube for blood
Collection MethodVenipuncture

Sample Stability

Blood sample stable for 48 hours at room temperature
Extracted DNA stable for longer periods if stored properly
Sample Rejection Criteria:
  • Hemolyzed or clotted blood samples
  • Insufficient sample volume
  • Incorrect labeling or missing patient information

Understanding Your Results

Results from the PTCH2 Gene NGS Test indicate whether a pathogenic mutation is detected. A positive result confirms a genetic predisposition to Basal Cell Nevus Syndrome, while a negative result suggests no mutation in the PTCH2 gene, though other genetic causes may exist.
📊

Pathogenic variant detected

Confirms diagnosis of BCNS due to PTCH2 mutation. Recommend genetic counseling, regular dermatological screenings, and family testing.

📊

No pathogenic variant detected

PTCH2 mutation not found. Consider testing for PTCH1 or other genes if clinical suspicion remains. Follow-up with clinical evaluation.

📊

Variant of uncertain significance (VUS)

Genetic change identified but clinical significance unknown. Requires further family studies and clinical correlation. Genetic counseling advised.

⚠️ When to Consult a Doctor:

Consult a doctor if you have multiple basal cell carcinomas, jaw cysts, or other symptoms of BCNS, especially with a family history. After testing, consult a genetic counselor or dermatologist to discuss results and management options.

Limitations

  • May not detect all types of mutations, such as large deletions or rearrangements
  • Results require interpretation by a genetic counselor or specialist
  • Does not rule out mutations in other genes like PTCH1 that may cause similar symptoms

Risks & Considerations

  • Minor bruising or discomfort at the blood draw site
  • Rare risk of infection from needle stick
  • Psychological impact of genetic results; counseling recommended

Interfering Factors

  • Sample contamination during collection or processing
  • Degraded DNA quality due to improper storage
  • Presence of inhibitors in the sample affecting sequencing

Frequently Asked Questions

What is Basal Cell Nevus Syndrome (BCNS)?
BCNS, or Gorlin-Goltz syndrome, is a rare genetic disorder characterized by multiple basal cell carcinomas, jaw cysts, and other developmental abnormalities. It is caused by mutations in the PTCH1 or PTCH2 genes.
What causes BCNS?
BCNS is primarily caused by germline mutations in the PTCH1 or PTCH2 genes, which are involved in the Hedgehog signaling pathway and tumor suppression.
How is BCNS diagnosed?
Diagnosis involves clinical evaluation of symptoms and genetic testing to identify mutations in the PTCH1 or PTCH2 genes. Imaging and biopsy may also be used.
What is the PTCH2 Gene NGS Genetic Test?
This test uses next-generation sequencing to analyze the PTCH2 gene for mutations associated with BCNS. It provides detailed genetic information for diagnosis and family screening.
Who should consider this test?
Individuals with multiple basal cell carcinomas, jaw cysts, palmar pits, or a family history of BCNS should consider this test for accurate diagnosis.
What is the cost of the test?
The cost of the PTCH2 Gene NGS Genetic Test at DNA Labs India is INR 20,000, which includes home sample collection across India.
How do I prepare for the test?
No special preparation is needed. Genetic counseling is recommended before testing. Provide your clinical and family history to the lab.
What sample is required?
The test requires a blood sample, extracted DNA, or one drop of blood on an FTA card.
How long does it take to get results?
Results are typically available within 3-4 weeks after sample collection.
What do the results mean?
A positive result indicates a PTCH2 mutation, confirming BCNS risk. A negative result means no mutation was found, but other genetic causes may exist. Genetic counseling helps interpret results.
Is the test painful?
The test involves a routine blood draw, which may cause minor discomfort or bruising. It is generally safe and quick.
Can this test be done at home?
Yes, DNA Labs India offers free home sample collection for this test in many cities across India. Book online for convenience.
Worried about the process? Our certified phlebotomists collect thousands of samples every month across India. The process takes under 5 minutes and is virtually painless. Questions? Message us on WhatsApp — we're here 7 days a week.

Related Tests

For Hospitals & Clinics

Reference Laboratory Services

We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.

LIMS Integration

Your Data Privacy

Your medical data is protected under Indian law.

Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.

DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.

Book Your Test

Enter your details and we'll connect you within 15 minutes.

🧬

Quick Connect

Enter your mobile number and we’ll connect you with the team.

+91

✅ Connecting you now...

🔒 Your number is used to respond to this request.